Law360's 2022 Life Sciences Editorial Advisory Board

Law360 (April 25, 2022, 12:07 PM EDT) -- Law360 is pleased to announce the formation of its 2022 Life Sciences Editorial Advisory Board.

The editorial advisory board provides feedback on Law360's coverage and expert insight on how best to shape future coverage.

The members of Law360's 2022 Life Sciences Editorial Advisory Board are:

D'Lesli Davis, Norton Rose Fulbright

D'Lesli Davis is Norton Rose Fulbright's U.S. head of life sciences and health care. She represents pharmaceutical and medical device clients in high-stakes litigation in state and federal courts across the country, in MDLs and consolidated proceedings, governmental actions, commercial, economic loss, and product liability matters.

Gary F. Giampetruzzi, Paul Hastings...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!